WORLDSymposium™ 2019 Registration Now Open

Plan to attend the 15th Annual WORLDSymposium February 4 – 8, 2019 in Orlando, Florida!

This symposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances.

Click here to register.

WORLDSymposium 2019 Online Abstract Submission Now Open

The categories for abstracts submitted to WORLDSymposium 2019 have expanded. Submissions will be accepted in two Basic Science categories, three Translational Research categories, or two Clinical Applications1,2 categories. The deadline for submitting an abstract to WORLDSymposium is October 1, 2018 for review by the Program Committee. Abstracts must be submitted with the intention that they will be presented if selected. First authors are expected to attend the meeting and make the presentation. Authors should not submit abstracts if they do not plan to attend the meeting. Click here for more information.

WORLDSymposium 2019 Award Nominations Now Open

Nominations for the Roscoe O. Brady Award for Innovation and Accomplishment and the Patient Advocate Leader Award opened July 1, 2018. Awards will be presented at WORLDSymposium 2019. Nominations Deadline will be August 15, 2018. Click here to submit an Award Nomination.

Monday, February 4, 2019: Opening Reception and Awards Ceremony

This year, Monday evening will include the presentation of WORLDSymposium Young Investigator and New Treatment Awards. Plan to arrive early for this special event.

Preliminary Schedule at A Glance

Day Monday
Feb. 4, 2019
Feb. 5, 2019
Feb. 6, 2019
Feb. 7, 2019
Feb. 8, 2019
6:15-7:15 AM Satellite Symposium Satellite Symposium Satellite Symposium
Morning Council of Patient Advocates (COPA) (9:00 AM-12:00 PM) Basic Science: Disease Mechanisms, Pathology, and Biomarkers of Lysosomal Diseases Translational Research: Implementation and Impact of Newborn Screening on Lysosomal Diseases; Clinical Trial Readiness – Preclinical Trial Methods and Studies for Lysosomal Diseases Clinical Trials for Registration1 Council of Research Experts (CORE) (8:00 AM-12:00 PM)
Lunch Satellite Symposium Satellite Symposium Satellite Symposium
Afternoon Emerging Trends 2019 (1:00-5:00 PM) Basic Science: Developing Therapeutic Approaches for Lysosomal Diseases in the Laboratory Translational Research: Gene Therapy for Lysosomal Diseases Clinical Trials: Improving Outcomes Post-Registration2
4:30-6:30 PM Poster Session Poster Session Networking Reception (4:30-5:30 PM)
5:15-6:30 PM Award Ceremony & Opening Reception
6:30-8:30 PM Satellite Symposium Satellite Symposium Satellite Symposium
1 Abstracts in the Clinical Trials for Registration category must have an FDA Investigational New Drug (IND) application (Phase I-III clinical trial), an EMA Investigational Medicinal Product Dossier (IMPD), or equivalent.
2 The Clinical Outcomes category includes licensed therapies (Phase IV) and non-interventional studies.

We’re Organizing Research on Lysosomal Diseases

Dates to Remember

July 1, 2018
Abstract submission website open.

August 1, 2018
Online registration and hotel reservations open. Exhibitor prospectus available by request.

October 1, 2018
Deadline for abstract submission to WORLDSymposium 2019.

October 1, 2018
Deadline for submission of full-length manuscripts for peer-review in the “Lysosomes” issue of Molecular Genetics & Metabolism, February, 2019.

November 1 – December 1,  2018
Late breaking abstract submission open.

November 15, 2018
Notification of abstract acceptance for poster or platform presentation at WORLDSymposium 2019.

About WORLDSymposium

The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases. This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.

The Editor

Chester B. Whitley, PhD, MDChester B. Whitley, PhD, MD
WORLDSymposia Editor